Market Cap
₹3,681 Cr.
P/E
29.50
Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max

Company Timeline

Company Timeline

Forensics
Other Income
Other Income is not affecting ratios of the company
Capex vs ROCE
ROCE of the company has decreased even without significant capex
Pledge
Promoters have not pledged a significant portion of their holding
Revenue Recognition
Chances of aggressive revenue recognition - Operating profit of company is not getting converted to cash and recievables rising faster than sales
Depreciation Effect
Depreciation accounting is not leading to increase in profits
Contingent Liabilities
Company does not have significant contingent liabilities
Retail Holding
Retail has been buying the stock which is usually a sign of exuberance
Share price
Share price has decreased over last 10 years more due to earnings
ROE
ROE has decreased vs 10 year trend
Working Capital
Working Capital of the company seems to be under control
Debt
Company should not have issues servicing its debt
Current vs Historic Valuation
Company is trading at a premium to 3yr historic valuations
Promoter Holding
Promoters has been selling shares in the open market over last 90 days
ROE
Latest
8.55%
3yr Average
11.52%
5yr Average
13.27%
Net Profit Margin
Latest
19.54%
3yr Average
23.74%
5yr Average
25.36%
ROCE
Latest
11.1%
3yr Average
15.09%
5yr Average
17.59%
Debt to Equity
Latest
0.01
3yr Average
0.01
5yr Average
0.02
Market Share
10% (as of Mar 18)
Nutraceuticals Segment Market Share
Show more
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Asset Break-Up

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    Select a Metric
    • Management Compensation as a % of Sales (%)
    • R&D as a % of Total Sales (%)
    Peer Comparison
    Company Filing
    Show Previous Years
    Discussions & Analysis